Michael Cruse

OKUR

Michael Cruse serves as Chief Operating Officer at OnKure Therapeutics, Inc. (OKUR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$67.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$67.3K

Companies Traded

OKUR

Active Period

Aug 2021 – Sep 2022

3 total trades

Most Recent

Buy OKUR

Sep 2, 2022 · $25.4K

Michael Cruse's Insider Trading at OnKure Therapeutics, Inc. (OKUR)

Buys

3 · $67.3K

Sells

0 · $0.00

Total Shares Bought

17,255

Total Shares Sold

OKUR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 2, 2022	Buy	7,500	$3.39	$25.4K	13,697
Aug 31, 2022	Buy	7,255	$3.20	$23.2K	31,758
Aug 26, 2021	Buy	2,500	$7.45	$18.6K	2,500

Related Insiders

Jason A. Leverone

officer: Chief Financial Officer

OKURSell · Mar 24, 2026

Nicholas A Saccomano

President and CEO

OKURSell · Mar 24, 2026

Explore More Insider Trading Data

OKUR Insider Trading Activity

View all insider trades at OnKure Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity